In 77 TNBC cases from the United States that were not selected for age or familial breast cancer occurrence, the mutation frequencies were 15.6% for BRCA1 (n = 12) and 3.9% for BRCA2 (n = 3). This evidence concerns the gene BRCA1 and breast carcinoma.